Upton, R., Banuelos, A., Feng, D., Biswas, T., Kao, K., McKenna, K., . . . Weissman, I. L. (2021). Combining CD47 blockade with trastuzumab eliminates HER2-positive breast cancer cells and overcomes trastuzumab tolerance. Proc Natl Acad Sci U S A.
Chicago ZitierstilUpton, Rosalynd, et al. "Combining CD47 Blockade With Trastuzumab Eliminates HER2-positive Breast Cancer Cells and Overcomes Trastuzumab Tolerance." Proc Natl Acad Sci U S A 2021.
MLA ZitierstilUpton, Rosalynd, et al. "Combining CD47 Blockade With Trastuzumab Eliminates HER2-positive Breast Cancer Cells and Overcomes Trastuzumab Tolerance." Proc Natl Acad Sci U S A 2021.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.